199 related articles for article (PubMed ID: 25148110)
41. Memory, attention, and executive functions before and after sine and pulse wave electroconvulsive therapies for treatment-resistant major depression.
Fujita A; Nakaaki S; Segawa K; Azuma H; Sato K; Arahata K; Otsuki K; Hori M; Mochida Y; Uchida M; Yamada T; Nakamura C; Akechi T; Furukawa TA
J ECT; 2006 Jun; 22(2):107-12. PubMed ID: 16801825
[TBL] [Abstract][Full Text] [Related]
42. [Dopamine system genes interaction and neurocognitive traits in patients with schizophrenia, their relatives and healthy controls from general population].
Alfimova MV; Golimbet VE; Gritsenko IK; Lezheĭko TV; Abramova LI; Strel'tsova MA; Khlopina IV; Ebstein R
Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(7):57-63. PubMed ID: 16921721
[TBL] [Abstract][Full Text] [Related]
43. Dopamine DRD2 Taq I polymorphism associates with caudate nucleus volume and cognitive performance in memory impaired subjects.
Bartrés-Faz D; Junqué C; Serra-Grabulosa JM; López-Alomar A; Moya A; Bargalló N; Mercader JM; Moral P; Clemente IC
Neuroreport; 2002 Jul; 13(9):1121-5. PubMed ID: 12151753
[TBL] [Abstract][Full Text] [Related]
44. The influence of cognitive reserve on memory following electroconvulsive therapy.
Legendre SA; Stern RA; Solomon DA; Furman MJ; Smith KE
J Neuropsychiatry Clin Neurosci; 2003; 15(3):333-9. PubMed ID: 12928509
[TBL] [Abstract][Full Text] [Related]
45. BDNF and COMT polymorphisms: relation to memory phenotypes in young adults with childhood-onset mood disorder.
Strauss J; Barr CL; George CJ; Ryan CM; King N; Shaikh S; Kovacs M; Kennedy JL
Neuromolecular Med; 2004; 5(3):181-92. PubMed ID: 15626819
[TBL] [Abstract][Full Text] [Related]
46. Early and long-term effects of electroconvulsive therapy and depression on memory and other cognitive functions.
Calev A; Nigal D; Shapira B; Tubi N; Chazan S; Ben-Yehuda Y; Kugelmass S; Lerer B
J Nerv Ment Dis; 1991 Sep; 179(9):526-33. PubMed ID: 1919554
[TBL] [Abstract][Full Text] [Related]
47. The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus.
Oroszi G; Lapteva L; Davis E; Yarboro CH; Weickert T; Roebuck-Spencer T; Bleiberg J; Rosenstein D; Pao M; Lipsky PE; Goldman D; Lipsky RH; Illei GG
Ann Rheum Dis; 2006 Oct; 65(10):1330-5. PubMed ID: 16606648
[TBL] [Abstract][Full Text] [Related]
48. Cognitive side effects of electroconvulsive therapy in adolescents.
Ghaziuddin N; Laughrin D; Giordani B
J Child Adolesc Psychopharmacol; 2000; 10(4):269-76. PubMed ID: 11191687
[TBL] [Abstract][Full Text] [Related]
49. RETRACTED: Electroconvulsive therapy and aerobic exercise training increased BDNF and ameliorated depressive symptoms in patients suffering from treatment-resistant major depressive disorder.
Salehi I; Hosseini SM; Haghighi M; Jahangard L; Bajoghli H; Gerber M; Pühse U; Kirov R; Holsboer-Trachsler E; Brand S
J Psychiatr Res; 2014 Oct; 57():117-24. PubMed ID: 25073431
[TBL] [Abstract][Full Text] [Related]
50. Association between categorization of emotionally-charged and neutral visual scenes and parameters of event-related potentials in carriers of different COMT, HTR2A, BDNF gene genotypes.
Vorobyeva EV; Ermakov PN; Borokhovski EF; Kovsh EM; Stoletniy AS
F1000Res; 2020; 9():446. PubMed ID: 32983417
[No Abstract] [Full Text] [Related]
51. Pattern of cognitive dysfunction in depressive patients during maintenance electroconvulsive therapy.
Rami-González L; Salamero M; Boget T; Catalan R; Ferrer J; Bernardo M
Psychol Med; 2003 Feb; 33(2):345-50. PubMed ID: 12622313
[TBL] [Abstract][Full Text] [Related]
52. Depression and anxiety in relation to catechol-O-methyltransferase Val158Met genotype in the general population: the Nord-Trøndelag Health Study (HUNT).
Baekken PM; Skorpen F; Stordal E; Zwart JA; Hagen K
BMC Psychiatry; 2008 Jun; 8():48. PubMed ID: 18578865
[TBL] [Abstract][Full Text] [Related]
53. Genetic contributions to age-related decline in executive function: a 10-year longitudinal study of COMT and BDNF polymorphisms.
Erickson KI; Kim JS; Suever BL; Voss MW; Francis BM; Kramer AF
Front Hum Neurosci; 2008; 2():11. PubMed ID: 18958211
[TBL] [Abstract][Full Text] [Related]
54. APOE, MAPT, and COMT and Parkinson's Disease Susceptibility and Cognitive Symptom Progression.
Paul KC; Rausch R; Creek MM; Sinsheimer JS; Bronstein JM; Bordelon Y; Ritz B
J Parkinsons Dis; 2016 Apr; 6(2):349-59. PubMed ID: 27061069
[TBL] [Abstract][Full Text] [Related]
55. Nicardipine improves the antidepressant action of ECT but does not improve cognition.
Dubovsky SL; Buzan R; Thomas M; Kassner C; Cullum CM
J ECT; 2001 Mar; 17(1):3-10. PubMed ID: 11281512
[TBL] [Abstract][Full Text] [Related]
56. Hippocampal volume as a predictor of short-term ECT outcomes in older patients with depression.
Lekwauwa RE; McQuoid DR; Steffens DC
Am J Geriatr Psychiatry; 2005 Oct; 13(10):910-3. PubMed ID: 16223970
[TBL] [Abstract][Full Text] [Related]
57. Modification of depression by COMT val158met polymorphism in children exposed to early severe psychosocial deprivation.
Drury SS; Theall KP; Smyke AT; Keats BJ; Egger HL; Nelson CA; Fox NA; Marshall PJ; Zeanah CH
Child Abuse Negl; 2010 Jun; 34(6):387-95. PubMed ID: 20403637
[TBL] [Abstract][Full Text] [Related]
58. Nicotine abstinence-induced cerebral blood flow changes by genotype.
Wang Z; Ray R; Faith M; Tang K; Wileyto EP; Detre JA; Lerman C
Neurosci Lett; 2008 Jun; 438(3):275-80. PubMed ID: 18499348
[TBL] [Abstract][Full Text] [Related]
59. The electroconvulsive therapy controversy: evidence and ethics.
Reisner AD
Neuropsychol Rev; 2003 Dec; 13(4):199-219. PubMed ID: 15000226
[TBL] [Abstract][Full Text] [Related]
60. The long-term impact of treatment with electroconvulsive therapy on discrete memory systems in patients with bipolar disorder.
MacQueen G; Parkin C; Marriott M; Bégin H; Hasey G
J Psychiatry Neurosci; 2007 Jul; 32(4):241-9. PubMed ID: 17653292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
